A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia
CNDO-109激活的自然杀伤细胞治疗高危急性髓系白血病患者的I期临床试验
期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2018.03.019
Fehniger, Todd A; Miller, Jeffrey S; Stuart, Robert K; Cooley, Sarah; Salhotra, Amandeep; Curtsinger, Julie; Westervelt, Peter; DiPersio, John F; Hillman, Timothy M; Silver, Nova; Szarek, Michael; Gorelik, Leonid; Lowdell, Mark W; Rowinsky, Eric